These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8548536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease.
    Martins-Filho OA, Eloi-Santos SM, Teixeira Carvalho A, Oliveira RC, Rassi A, Luquetti AO, Rassi GG, Brener Z.
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1107-13. PubMed ID: 12204967
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
    Alessio GD, Côrtes DF, Machado de Assis GF, Júnior PA, Ferro EA, Antonelli LR, Teixeira-Carvalho A, Martins-Filho OA, de Lana M.
    J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
    [Abstract] [Full Text] [Related]

  • 5. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease.
    Cordeiro FD, Martins-Filho OA, Da Costa Rocha MO, Adad SJ, Corrêa-Oliveira R, Romanha AJ.
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):112-8. PubMed ID: 11139203
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
    Gazzinelli RT, Galvao LM, Krautz G, Lima PC, Cancado JR, Scharfstein J, Krettli AU.
    Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lytic antibodies in Trypanosoma cruzi-infected persons with low parasitemia.
    Zulantay I, Venegas J, Apt W, Solari A, Sanchez G.
    Am J Trop Med Hyg; 1998 Jun; 58(6):775-9. PubMed ID: 9660462
    [Abstract] [Full Text] [Related]

  • 10. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA, de Titto EH, Segura EL.
    Acta Trop; 1996 Dec 16; 62(3):151-62. PubMed ID: 9025983
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.
    Umekita LF, Ramos DP, Barbaro KC, Mota I.
    Immunol Lett; 1999 Nov 01; 70(2):73-6. PubMed ID: 10569694
    [Abstract] [Full Text] [Related]

  • 15. Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies.
    Lima-Martins MV, Sanchez GA, Krettli AU, Brener Z.
    Parasite Immunol; 1985 Jul 01; 7(4):367-76. PubMed ID: 3929211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.
    Matsumoto TK, Hoshino-Shimizu S, Nakamura PM, Andrade HF, Umezawa ES.
    J Clin Microbiol; 1993 Jun 01; 31(6):1486-92. PubMed ID: 8314991
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.